• AcelRx to Acquire Tetraphase americanpharmaceuticalreview
    March 19, 2020
    AcelRx Pharmaceuticals announced a definitive merger agreement to acquire Tetraphase Pharmaceuticals in a stock for stock deal at an exchange ratio of 0.6303 shares of AcelRx ...
  • Tetraphase Pharmaceuticals to merge with AcelRx pharmaceutical-technology
    March 18, 2020
    AcelRx Pharmaceuticals has executed a definitive merger agreement to acquire Tetraphase Pharmaceuticals in a stock-based transaction.
  • AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March biospace
    March 06, 2018
    AcelRx Pharmaceuticals, Inc today announced that that Vincent J. Angotti, Chief Executive Officer, will be presenting at the 30th Annual ROTH Conference, the 38th Annual Cowen Health Care Conference and the 28th Annual Oppenheimer Healthcare Conference.
PharmaSources Customer Service